User Performance Evaluation of the INRatio® Prothrombin Time (PT) Monitoring System With a New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity
NCT01036646 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 183
Last updated 2013-02-11
Summary
This multi-center study is designed to evaluate the ability of intended lay users (patients on oral anticoagulation therapy, OAT, or their caregivers) to 1) operate the INRatio Prothrombin Time (PT) Monitoring System utilizing the INRatio test strip newly designed for low sample volume and heparin insensitivity, and 2) obtain accurate results for the quantitative determination of International Normalized Ratio (INR) when self-testing using fingerstick capillary blood. Patients will be trained by their healthcare provider using the instructions for use and product labeling provided. The accuracy of the patient INR results will be assessed by comparison to the INR results obtained by the site's trained healthcare professional using the same INRatio system (from a separate fingerstick collected from the same patient at the point-of-care), and with the INR results obtained on venous plasma obtained from the same patient and analyzed at a central laboratory with the Sysmex CA-560 System INR reference method.
Conditions
- Oral Anticoagulation
Sponsors & Collaborators
-
Abbott RDx Cardiometabolic
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-08-31
- Primary Completion
- 2010-06-30
- Completion
- 2010-09-30
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL)
NCT03682419 ·Status: COMPLETED ·Phase: NA
-
Assessing the Ability of Warfarin Treated Patients to Predict Their INR
NCT02764112 ·Status: COMPLETED
-
Study to Test the Accuracy of a Prototype Handheld PT/INR Device
NCT01349712 ·Status: UNKNOWN
-
Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood
NCT01375725 ·Status: COMPLETED
-
Variability of Whole Blood Clotting Time Measurements in Ex Vivo Human Blood Samples Spiked With Anticoagulants
NCT03296982 ·Status: COMPLETED
-
XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis
NCT02506985 ·Status: TERMINATED ·Phase: PHASE4
-
Blood Donation From Warfarin Users for the Development of POC INR Monitor
NCT02355730 ·Status: UNKNOWN ·Phase: NA
-
Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients
NCT05926518 ·Status: COMPLETED
-
PT/INR Reference Interval IN Healthy Volunteers
NCT02319109 ·Status: COMPLETED
-
Accuracy of a Portable International Normalized Ratio Monitor in Elderly Patients
NCT01930916 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
NCT02376803 ·Status: COMPLETED ·Phase: PHASE4
-
Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban
NCT04169269 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluating Medication Adherence to Novel Oral Anticoagulants With Anticoagulant Activity Monitoring in Patients With Atrial Fibrillation
NCT03666962 ·Status: UNKNOWN
-
Remote Home Prothrombin Time (PT)/International Normalized Ratio (INR) Monitoring and Patient Management System
NCT00978445 ·Status: COMPLETED ·Phase: NA
-
AntiCoagulation Tracking InterVention and Evaluation
NCT04059965 ·Status: WITHDRAWN ·Phase: NA
-
Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin
NCT03516656 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Patient Self Testing of Warfarin Therapy
NCT00594828 ·Status: UNKNOWN ·Phase: PHASE4
-
Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients
NCT00814177 ·Status: COMPLETED ·Phase: PHASE2
-
Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma
NCT03339349 ·Status: COMPLETED ·Phase: PHASE2
-
Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose
NCT02704052 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Fiix-prothrombin Time for Monitoring Warfarin
NCT01565239 ·Status: COMPLETED ·Phase: PHASE2
-
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2
NCT02371070 ·Status: COMPLETED
-
Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.
NCT00056550 ·Status: COMPLETED ·Phase: PHASE3
-
INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)
NCT04117048 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin
NCT02970032 ·Status: COMPLETED ·Phase: EARLY_PHASE1